International Ophthalmology

, Volume 38, Issue 5, pp 1915–1922 | Cite as

The association of Helicobacter pylori with choroidal and retinal nerve fiber layer thickness

  • Mehmet Erol CanEmail author
  • Fatma Efe Kaplan
  • Mehmet Murat Uzel
  • Hasan Kiziltoprak
  • Mustafa Cagri Ergun
  • Mustafa Koc
  • Gülcin Simsek
Original Paper



To investigate the effect of Helicobacter pylori (H. pylori) infection on choroidal thickness (CT) and retinal nerve fiber layer thickness (RNFLT).


The study included 25 patients with H. pylori infection and 25 healthy individuals as the control group. Helicobacter pylori patients were classified as the pre-treatment (Group 1; n: 25) and the post-treatment (Group 2; n: 25). RNFLT and CT were measured before and after treatment of H. pylori infection, using enhanced depth imaging (EDI) spectral-domain optical coherence tomography (Spectralis, Heidelberg Engineering, Heidelberg, Germany). The axial length and intraocular pressure were also measured.


The mean subfoveal CT was 320.96 ± 29.15 μm in Group 1 and 287.48 ± 49.17 in the control group (p = 0.007), while the mean subfoveal CT did not show any difference between Group 2 and the control group (p > 0.05). No statistically significant difference was determined between the H. pylori patients and the control group in respect of RNFLT values (p > 0.05).


CT increases during H. pylori infection and returns to the normal range within 6 weeks of treatment. RNFLT does not show any change during H. pylori infection. The data related to the subfoveal CT may be useful in understanding the pathogenesis of central serous chorioretinopathy developing in H. pylori patients.


Enhanced depth imaging optical coherence tomography (EDI-OCT) Choroidal thickness Retinal nerve fiber layer thickness Helicobacter pylori infection Helicobacter pylori eradication 



The authors report no conflict of interests. The authors alone are responsible for the content and writing of the paper.

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interests to disclose.


  1. 1.
    Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347:1175–1186CrossRefGoogle Scholar
  2. 2.
    Parsonnet J, Shmuely H, Haggerty T (1999) Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 282:2240–2245CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Malaty HM (2007) Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21:205–214CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Cardenas VM, Mulla ZD, Ortiz M, Graham DY (2006) Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 163:127–134CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Franceschi F, Gasbarrini A (2007) Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol 21:325–334CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Realdi G, Dore MP, Fastame L (1999) Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 44:229–236CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Arslan E, Atilgan H, Yavaşoğlu I (2009) The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 20:695–697CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Ersoy O, Ersoy R, Yayar O et al (2007) H pylori infection in patients with Behcet’s disease. World J Gastroenterol 13:2983–2985CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Mindel JS, Rosenberg EW (1997) Is Helicobacter pylori of interest to ophthalmologists? Ophthalmology 104:1729–1730CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Cotticelli L, Borrelli M, D’Alessio AC et al (2006) Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 16:274–278CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Saccà SC, Pascotto A, Venturino GM et al (2006) Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci 47:501–508CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Kim JM, Kim SH, Park KH et al (2011) Investigation of the association between Helicobacter pylori infection and normal tension glaucoma. Invest Ophthalmol Vis Sci 52:665–668CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Chey WD, Wong BCY, Practice Parameters Committee of the American College of Gastroenterology (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102:1808–1825CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Garza-González E, Perez-Perez GI, Maldonado-Garza HJ, Bosques-Padilla FJ (2014) A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol 20:1438–1449CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Spaide RF, Koizumi H, Pozzoni MC, Pozonni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Mateo-Montoya A, Mauget-Faÿse M (2014) Helicobacter pylori as a risk factor for central serous chorioretinopathy: literature review. World J Gastrointest Pathophysiol 5:355–358CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Testerman TL, Morris J (2014) Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol 20:12781–12808CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Chmiela M, Gajewski A, Rudnicka K (2015) Helicobacter pylori vs coronary heart disease - searching for connections. World J Cardiol 7:187–203CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Aragona P, Magazzù G, Macchia G et al (1999) Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren’s syndrome. J Rheumatol 26:1306–1311PubMedPubMedCentralGoogle Scholar
  20. 20.
    Argenziano G, Donnarumma G, Iovene MR et al (2003) Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol 42:601–604CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Baykal C, Buyukbabani N, Akinturk S, Saglik E (2006) Prurigo pigmentosa: not an uncommon disease in the Turkish population. Int J Dermatol 45:1164–1168CrossRefGoogle Scholar
  22. 22.
    Huang X, Qu X, Yan W et al (2010) Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J 86:272–278CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Windle HJ, Kelleher D, Crabtree JE (2007) Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics 119:754–759CrossRefGoogle Scholar
  24. 24.
    Rosenstock SJ, Jørgensen T, Andersen LP, Bonnevie O (2000) Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 28:32–40PubMedPubMedCentralGoogle Scholar
  25. 25.
    Wotherspoon AC, Doglioni C, Diss TC et al (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet (London, England) 342:575–577CrossRefGoogle Scholar
  26. 26.
    Graham DY, Lew GM, Klein PD et al (1992) Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116:705–708CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Wong BC-Y, Lam SK, Wong WM et al (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291:187–194CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Raghunath A, Hungin APS, Wooff D, Childs S (2003) Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326:737CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Oldenburg B, Diepersloot RJA, Hoekstra JBL (1996) High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 41:458–461CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Abdel-Hady H, Zaki A, Badra G et al (2007) Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 37:1026–1033CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Kerr JR (2000) An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection. Arch Dis Child 83:429–434CrossRefPubMedCentralGoogle Scholar
  32. 32.
    Portnoi VA (1997) Helicobacter pylori infection and anorexia of aging. Arch Intern Med 157:269CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Saccà SC, Vagge A, Pulliero A, Izzotti A (2014) Helicobacter pylori infection and eye diseases. Medicine (Baltimore) 93:216CrossRefGoogle Scholar
  34. 34.
    Portal-Celhay C, Perez-Perez GI (2006) Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci 110:305–314CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Byrne MF, Kerrigan SW, Corcoran PA et al (2003) Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 124:1846–1854CrossRefPubMedCentralGoogle Scholar
  36. 36.
    Handin RI (2003) A hitchhiker’s guide to the galaxy—an H. pylori travel guide. Gastroenterology 124:1983–1985CrossRefPubMedCentralGoogle Scholar
  37. 37.
    Spaide RF, Yannuzzi LA, Slakter JS et al (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15:100–110CrossRefPubMedCentralGoogle Scholar
  38. 38.
    Talks J, Koshy Z, Chatzinikolas K (2007) Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration. Br J Ophthalmol 91:600–601CrossRefPubMedCentralGoogle Scholar
  39. 39.
    Fanea L, Fagan AJ (2012) Review: magnetic resonance imaging techniques in ophthalmology. Mol Vis 18:2538–2560PubMedPubMedCentralGoogle Scholar
  40. 40.
    Wolff-Korman PG, Kormann BA, Hasenfratz GC, Spengel FA (2009) Duplex and color Doppler ultrasound in the differential diagnosis of choroidal tumors. Acta Ophthalmol 70:66–70CrossRefGoogle Scholar
  41. 41.
    Kim S-W, Oh J, Kwon S-S et al (2011) Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina 31:1904–1911CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Ulusoy DM, Duru N, Ataş M et al (2015) Measurement of choroidal thickness and macular thickness during and after pregnancy. Int J Ophthalmol 8:321–325PubMedPubMedCentralGoogle Scholar
  43. 43.
    Kim JW, Park MH, Kim YJ, Kim YT (2016) Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia. Eye (Lond) 30:349–354CrossRefGoogle Scholar
  44. 44.
    Esmaeelpour M, Považay B, Hermann B et al (2011) Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci 52:5311–5316CrossRefPubMedCentralGoogle Scholar
  45. 45.
    Akay F, Gundogan FC, Yolcu U et al (2016) Choroidal thickness in systemic arterial hypertension. Eur J Ophthalmol 26:152–157CrossRefPubMedCentralGoogle Scholar
  46. 46.
    Duru N, Altinkaynak H, Erten Ş et al (2016) Thinning of Choroidal thickness in patients with rheumatoid arthritis unrelated to disease activity. Ocul Immunol Inflamm 24:246–253CrossRefPubMedCentralGoogle Scholar
  47. 47.
    Altinkaynak H, Duru N, Uysal BS et al (2016) Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocul Immunol Inflamm 24:254–260PubMedPubMedCentralGoogle Scholar
  48. 48.
    Karalezli A, Eroglu FC, Kivanc T, Dogan R (2014) Evaluation of choroidal thickness using spectral-domain optical coherence tomography in patients with severe obstructive sleep apnea syndrome: a comparative study. Int J Ophthalmol 7:1030–1034PubMedPubMedCentralGoogle Scholar
  49. 49.
    Mauget-Faÿsse M, Kodjikian L, Quaranta M et al (2002) Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study. J Fr Ophtalmol 25:1021–1025PubMedPubMedCentralGoogle Scholar
  50. 50.
    Casella AMB, Berbel RF, Bressanim GL et al (2012) Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo) 67:1047–1052CrossRefGoogle Scholar
  51. 51.
    Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E et al (2008) Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection. Arch Soc Esp Oftalmol 83:177–182PubMedPubMedCentralGoogle Scholar
  52. 52.
    Kountouras J, Mylopoulos N, Boura P et al (2001) Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology 108:599–604CrossRefPubMedCentralGoogle Scholar
  53. 53.
    Zeng J, Liu H, Liu X, Ding C (2015) The relationship between Helicobacter pylori infection and open-angle glaucoma: a meta-analysis. Invest Ophthalmol Vis Sci 56:5238–5245CrossRefPubMedCentralGoogle Scholar
  54. 54.
    Franceschi F (2002) Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 106:430–434CrossRefPubMedCentralGoogle Scholar
  55. 55.
    Kusters JG, van Vliet AHM, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 19:449–490CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  1. 1.Department of OphthalmologyKecioren Training and Research HospitalAnkaraTurkey
  2. 2.Department of Internal MedicineKecioren Training and Research HospitalAnkaraTurkey
  3. 3.Department of OphthalmologyElmadag State HospitalAnkaraTurkey
  4. 4.Department of OphthalmologyUlucanlar Eye Training and Research HospitalAnkaraTurkey
  5. 5.Department of PathologyKecioren Training and Research HospitalAnkaraTurkey

Personalised recommendations